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I 
ABSTRACT 
Investigation of the biosynthetic process of indigoidine 
By 
Yi Chen, Master of Science 
Utah State University, 2019 
Major professor: Jixun Zhan 
Department: Biological Engineering 
Indigoidine (5,5′-diamino-4,4′-dihydroxy-3,3′-diazadiphenoquinone-(2,2′)) 
is a natural product synthesized by a non-ribosomal peptide synthetase (NRPS). It 
features a unique bright blue color similar to industrial dye indigo. It has antioxidant 
and antimicrobial activities, and the responsible gene can be used as a reporter 
system for gene expression. Several bacterial strains have the potential to produce 
indigoidine. However, some hosts have silent indigoidine biosynthetic genes, while 
others have very limited production of indigoidine. Heterologous expression of the 
responsible synthetase gene will significantly benefit its large-scale production and 
industrial applications. 
Previously, we cloned a putative indigoidine synthetase gene (Sc-indC) 
from Streptomyces chromofuscus ATCC 49982. Heterologous expression of the Sc-
indC in Escherichia coli (E. coli) achieved indigoidine production of 20 g/L under 
optimized conditions. Exploring the biosynthetic mechanism of indigoidine will 
potentially open new doors for further improvement of the production of this 
natural dye. 
II 
As NRPSs, most indigoidine synthetases were predicted to have four 
functional domains:  adenylation domain (A), thiolation (T), thioesterase (TE), and 
a special oxidation (Ox) integrated into the A domain, except that Sc-IndC has an 
additional C-terminal 4-oxalocrotonate tautomersase (4-OT) domain. It was 
proposed that the A domain activates the substrate L-glutamine (L-Gln), and 
transfers it to the T domain, where the TE domain catalyzes the cyclization to 
produce the intermediate pyro-glutamine (pyro-Gln). The intermediate compound 
was then released from T domain as a free molecule, and subsequently oxidized by 
the Ox domain, yielding 5-amino-3H-pyridine-2,6-one, which is finally dimerized 
to produce indigoidine. However, the proposed biosynthetic mechanism has not 
been confirmed and the sequence of the oxidation and cyclization still remains 
unknown. 
Although Sc-IndC has been reconstituted in E. coli BAP1 with higher 
activity, we found it had relatively lower in vitro activity compared to BpsA. So, 
my study was mainly focused on the biosynthetic mechanism of indigoidine by 
BpsA and Sc-IndC. The corresponding genes bpsA and Sc-indC were derived from 
two different bacteria.  
Firstly, I cloned and heterologously expressed bpsA, Sc-indC, and their gene 
fragments in E. coli BAP1, and then purified the recombinant proteins. Then, I 
chemically synthesized L-glutamine-SNAC, which mimics the thiolated glutamine 
in the biosynthetic process. Finally, I optimized the in vitro enzyme assay 
conditions to test the enzymatic activity of the purified intact enzymes and domains 
on the substrate L-glutamine, and the intermediates L-glutamine-SNAC and 3-
III 
aminopiperidine-2,6-dione (pyro-Gln). The products were analyzed by LC-MS to 
reveal the biosynthetic process of indigoidine by BpsA and Sc-IndC. My results 
showed that in the presence of ATP, BpsA can convert substrate L-glutamine, the 
intermediates L-glutamine-SNAC and 3-aminopiperidine-2,6-dione to indigoidine. 
IV 
PUBLIC ABSTRACT 
Investigation of the biosynthetic process of indigoidine 
By 
Yi Chen, Master of Science 
Utah State University, 2019 
Major professor: Jixun Zhan 
Department: Biological Engineering 
Indigoidine is a natural blue dye with antioxidant and antimicrobial 
activities. It has also been used as an indicator for gene expression based on its 
distinctive blue color. Similar to the industry blue dye indigo, indigoidine has a 
promising potential to be applied in industry as a blue dye. However, the 
indigoidine production level in the original microorganisms was very low. 
Heterologous expression of the responsible synthetase gene in Escherichia coli can 
facilitate the fast and large-scale production of indigoidine. Also, a good 
understating of the working mechanism of the synthetase is favorable for the 
industrial application.  
In our previous study, a putative indigoidine synthetase gene (Sc-indC) has 
been heterologously expressed in E. coli, and 20 g/L of indigoidine was produced 
under optimized culture conditions. To further improve the production, we intended 
to explore the indigoidine biosynthetic process by studying the working mechanism 
of two indigoidine synthetases BpsA and Sc-IndC from two different bacteria. 
Both BpsA and Sc-IndC were predicted to have similar domain architecture 
that consists of an adenylation domain (A) with an embedded oxidation (Ox) 
V 
domain, thiolation (T) domain, and thioesterase (TE) domain, except that Sc-IndC 
has an additional C-terminal. To explore the enzymatic mechanism, I dissected the 
gene between domains to get A-Ox-T/TE and A-Ox/T-TE, and co-expressed the 
dissected fragments to find out whether they can work in the combination of pieces 
as the intact enzymes do. On the other hand, I separately expressed the domains in 
E. coli BAP1 and purified the resulting proteins, and tested the in vitro activities on
precursors individually or in different combinations. My results showed that the 
intact enzymes can convert glutamine, glutamine-SNAC and pyor-Gln to 
indigoidine in the presence of ATP. However, none of the dissected enzymes 
showed the ability to form the blue dye in vitro or in vivo. 
VI 
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CHAPTER I INTRODUCTION 
1.1 Background 
Introduction of indigo. 
Indigo (indigotin, or 2,2'-Bis (2,3-dihydro-3-oxoindlyliden) features 
distinctive bright blue color and has been broadly used for textile dyeing, printing, 
food, and cosmetic applications 1. Since the 19th century, the worldwide demand 
of blue jeans and denim cloth has been dramatically increased, accordingly the 
production of indigo also intensely amplified 1b, 2. In 2011, 50,000 tons of indigo 
was produced, of which up to 95% was applied in the dying of denim cloth 3. 
Originally indigo was a rare natural dye. It was extracted from the leaves 
of the plant genus Indigofera, specifically Indigofera tinctoria (or I. sumatrana), 
which was mainly distributed in tropics, and predominantly in India1a, 1b, 4. People 
who resided in less-warm areas, such as China, Japan, and Europe, also 
alternatively extracted blue dye from native plants such as Strobilanthes cusiaw, 
Persicaria tinctoria, Polygonum tinctorum, and Isatis tinctoria; another optional 
source was the sea snail mollusk 1a, 1b, 4. However, the production of these blue-
dyes were of low concentration and purity, and easily tinged by other dye. So the 
true indigo production was mainly originated from I. tinctoria, which was very 
limited and rare. Hence people traded it as a luxury product and referred it as blue 
gold 1b. Though later broad plantation brought relatively higher production, the 
labor work was arduous and the production was highly environment-dependent. 
The supply was still far less than the growing demand. For centuries, the plant–
2 
 
derived indigo was the only source of this blue dye. Figure 1 shows the pathway 
of indigo in plant. 
 
Figure 1 Chemical transformations occurred in the processing of the leaves in 
dyeing with indigo 1b. 
In the 1860s, chemists started to develop strategies to chemically 
synthesize this compound. In 1870, the German chemist Adolf von Baeyer firstly 
synthesized indigo from isatin. Later on he developed several other methods, but 
all were in laboratory scale 5. To achieve the industrious production, Heumann 
developed a strategy to heat the precursor N-(2-carboxyphenyl)glycine with 
sodium hydroxide, and subsequently decarboxylated the resulting product to form 
indoxyl, which was immediately oxidized as indigo dye in air.  In the 1990s, 
Johannes Pfleger realized the commercial production in large scale. They 
produced the single unit indoxyl in one step through N-phenylglycine under harsh 
base condition1b, 6. Since then, almost all of the indigo dye has been produced by 
chemical synthesis 7. Nowadays, thousands of tons of indigo is produced 
anniversary. However, mass chemical production unenviably brings serious 
environmental pollution and material waste.  
Microbial production of indigo could be an eco-friendly and high-efficient 
strategy. It has been reported that microorganisms also produced indigo. In recent 
years, biosynthetic pathway has been developed in E. coli to “naturally” produce 
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indigo from indole 8. However, the production has been in small scale and merely 
satisfies the huge industrial demand. 
 
Figure 2 Chemical synthesis of indigo based on Heumann‐Pfleger process. 
 
Figure 3 Transformation of indigo in the dyeing process. 
Indigo has good solubility in DMSO, but is less soluble in water and other 
organic solvents, since it’s easy for this molecule to form intra- and 
intermolecular hydrogen bond. A suppression on the formation of intramolecular 
hydrogen bond might help with the solubility. During the dyeing process with 
indigo, the low solubility makes the dyeing challenging. Usually reductant agent 
is required to convert indigo into a soluble form, which is leuco-indigo, also 
known as indigo white. The soluble indigo white physically attaches to the fabric, 
and returns to indigo after being oxidized in the air, turning the fabric from 
yellow-green to blue 9. Dying pigment has been a big problem of the water 
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pollution, and the tough reducing condition of the dying with indigo make it more 
hazardous. 
 
Figure 4 Chemical structures for indigo and its colorant derivatives. 
The chemical structure of indigo features a planar conjugation system of 
adjacent double bonds, which contributes to its distinctive blue color (λmax = 613 
nm). The modification of indigo molecule provides many different derivative 
colorants, such as indigo carmine, thioindigo, tyrian purple (6,6'-dibromoindigo. 
6-bromoindigo), and ciba blue (5,7,5′,7′-tetrabromoindigo). Indigo carmine is the 
salt form of chemically synthesized indigo. It was listed as one of the rare blue 
colorant, FD&C Blue No. 2, applied in food and cosmetic industry10. 
Introduction of indigoidine. 
Indigoidine (5,5′-diamino-4,4′-dihydroxy-3,3′-diazadiphenoquinone-
(2,2′)) is a non-ribosomal peptide synthetase (NRPS)-associated natural product. 
It features a distinct blue color similar to indigo, thus named as indigodine.  While 
chemically synthesized indigo might bring health risks, the naturally produced 
indigoidine has an advantage of antioxidant and anti-microbial activities 11 12. 
Owing to the highly oxidized and conjugated system in the chemical structure, 
indigoidine acts as scavenger for free radicals, hence is less stable in liquid, 
especially at high temperature, which makes it degradable and less-threatening to 
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the water system. These properties make indigoidine a promising excellent 
substitution of indigo as blue dye.  
Due to its bright blue color, the responsible indigoidine synthetase gene 
has been introduced to both E. coli and mammalian cells to construct reporter 
system, which has been used as a visual indicator to high-throughput screen gene 
expression. This was the first report that NRP could be produced by engineered 
mammallian cells 13. The indigoidine synthetase BpsA has also been developed as 
a reporter to screen PPTase and PPTase inhibitors 14, as well as PPTase-associated 
natural product biosynthetic genes 15. 
Previous studies showed that the indigoidine synthetase were present in 
different strains (Table 1). However, this gene was silent in some of these strains, 
while other bacteria had very limited production of indigoidine. Through 
regulatory gene manipulation and heterologous expression, activation and 
enhancement of indigoidine production can be achieved. To activate the 
indigoidine NRPS, a 4’-phosphopantetheinyl transferase (PPTase) is required, 
which transforms the indigoidine synthetase to the holo form by adding the 
phosphopantetheinyl group from coenzyme A (CoA) to the T domain 13 16. It was 
proved that the disruption of farR2 gene could lead to delayed production of 
indigoidine in Streptomyces lavendulae FRI-5 17, and the disruption of either pecS 
or pecM in Streptomyces lavendulae gene cluster could repress the indigoidine 
production 11 18. By replacing the promotor of ORF with strong constitutive rpsM 
promoter, the silent Sc-indC gene in Photorhabdus luminescens was successfully 
activated to produce the blue pigment 16. 
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The indigoidine synthetase BpsA contains one single module, which is 
predicted to consist of an adenylation (A) domain, thiolation (T) domain, 
thioesterase (TE) domain, and a special oxidation (Ox) domain integrated in the A 
domain. Sc-IndC has the same domain organization except that it has an 
additional C-terminal 4-oxalocrotonate tautomersase (4-OT) domain. The native 
substrate L-glutamine (L-Gln) is activated by the A domain as amino acyl 
adenylates (acyl-adenylated L-Gln), and transferred to the activated T domain, 
where it is hydrolyzed and cyclized by the TE domain to form and release the 
intermediate 5-aminopiperidine-2,6-dione. The single molecule is further oxidized 
by the Ox domain, and dimerized in air to yield indigoidine 11, 19. However, it is 
also possible that the oxidation happens when the substrate is linked to the T-
domain 19. In this case, T-tethered L-Gln is firstly oxidized by the Ox domain, and 
then cyclized and released from the enzyme by the TE domain 20.  
Table 1 Strains possessing an indigoidine biosynthetic gene cluster. 
Strains Ref. 
Arthrobacter atrocyaneus 18 
Arthrobacter crystallopoietes 21 
Arthrobacter polychromogenes 22 
Corynebacterium insidiosum 23 
Erwinia chrysanthemi 11 18 24 25 
Phaeobacter sp. 12 
Photorhabdus luminescens 16 
Pseudomonas indigofera 26 
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Streptomyces lavendulae 13 17 19 
Streptomyces aureofaciens 27 
Streptomyces chromofuscus 28 
1.2 Objectives 
To be used in the industry, efficient production of the indigoidine blue dye 
is necessary 29. In our previous study, a putative indigoidine synthetase gene (Sc-
indC) was cloned from Streptomyces chromofuscus ATCC 49982 28. 
Heterologous expression of Sc-indC in E. coli achieved indigoidine production of 
20 g/L under optimized conditions. Reportedly, fed-batch fermentation of an 
engineered fungi Rhodosporidium toruloides with bpsA also produced indigoidine 
reaching titers of 86.3 7.4 g/L30. Exploring the mechanisms of indigoidine 
synthesis would potentially open new doors to further improve the production or 
create new indigoidine derivatives. Though arduous studies have been done on 
NRPSs, the synthetic mechanism of indigoidine through such a simple mono-
module NRPS is still unknown.  To better understand the enzymatic mechanism 
of NRPSs, this study was aimed to explore the biosynthetic process of indigoidine 
by working on bpsA and Sc-indC. 
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CHAPTER II MATERIALS AND METHODS 
2.1 General Methods 
Products were analyzed and purified on an Agilent (Santa Clara, CA, 
USA) 1200 HPLC instrument equipped with a UV detector and a C18-reversed 
phase HPLC column (4.6 × 250 mm, 50 μm KANTO Reagents, Japan). ESI-MS 
spectra were obtained on an Agilent 6130 quadrupole LC-MS. NMR spectra were 
recorded on a Bruker (Billerica, MA, USA) NMR instrument (500 MHz for 1H 
NMR). The chemical shift (δ) values were given in parts per million (ppm). The 
coupling constants (J values) were reported in Hertz (Hz). 
2.2 Strains, Media and Culture Conditions 
Streptomyces chromofuscus ATCC 49982 and Streptomyces lavendulae 
ATCC 11924 were obtained from the American Type Culture Collection (ATCC). 
They were grown at 30℃ in YEME medium 1 for the extraction of genomic 
DNA. E. coli XL1-Blue was used for routine cloning and amplification; E. coli 
BAP1 was used for protein expression. They were grown at 37°C on Luria–
Bertani (LB) agar plates or in liquid LB medium supplemented with appropriate 
antibiotics (ampicillin, 50 μg/ml; kanamycin, 50 μg/ml; streptomycin, 50 μg/ml). 
When OD600 value reached 0.4~0.6, the expression host E. coli BAP1 was 
induced with 200 μM of isopropyl-1-thio--D-galactopyranoside (IPTG), and 
incubated at 18°C or 28°C for enzyme expression. 
2.3 Gene Manipulation and Plasmid Construction 
Restriction enzymes, Phusion® High-Fidelity DNA polymerase, and T4 
DNA ligase were purchased from New England Biolabs (Ipswich, MA, USA). 
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The GeneJETTM Plasmid Miniprep Kit and GeneJETTM PCR Purification Kit were 
purchased from Fermentas (Glen Burnie, MD, USA) for plasmids extraction and 
gel purification. The CloneJET™ PCR Cloning Kit was purchased from 
Fermentas (Glen Burnie, MD, USA) for DNA cloning and sequencing. The 
pET28a and pCDFDuet-1 vectors were purchased from Novagen (Madison, WI, 
USA) for protein expression in E. coli BAP1. The Sc-indC gene 2 and bpsA gene 3 
were cloned from the genome of Streptomyces chromofuscus ATCC 49982 and S. 
lavendulae ATCC 11924, respectively. The primers for PCR amplification were 
shown in Table 2. The PCR products were gel purified and ligated into the 
pJET1.2 cloning vector to yield pFC12 and pFC13, respectively (Table 3). The 
genes were confirmed by digestion check and DNA sequencing.  
The genes were excised from pFC12 and pFC13 via NdeI/HindIII, and 
ligated to pET28a between the same sites to form pFC15 and pFC14 (Table 3). 
The Sc-indC and bpsA related gene fragments were amplified by PCR from 
pFC15 and pFC14 using corresponding primers (Table 2). Similarly, those genes 
were gel purified and ligated into the pJET1.2 for amplification (Table 3). After 
confirmed by digestion check and DNA sequencing, they were excised from 
pJET1.2-derived plasmids, and ligated to pET28a or pCDFDuet-1 (Table 3). The 
Sc-indC-A-Ox, bpsA-TE, and bpsA-Ox genes were amplified by PCR and purified 
with the PCR purification Kit. After digesting with appropriate sites, they were 
directly ligated to pET28a to yield pFC147, pFC146, and pFC148, respectively. 
The primers were designed based on the Sc-indC and bpsA sequences and 
synthesized by Invitrogen (Carlsbad, CA, USA). 
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Table 2 Primers used for PCR amplification in this study. 
Primer Sequence (5′-3′) Gene size Product 
Sc-indC-PacI-NdeI-5 TTAATTAACATATGAGCGTAGAGACCATCCCCTGCT 4,134 bp Sc-indC 
Sc-indC-HindIII-NheI-3 AAGCTTGCTAGCTTTCAGTAGTTGGGCGTCTTGC 
Sc-indC-PacI-NdeI-5 TTAATTAACATATGAGCGTAGAGACCATCCCCTGCT 3,084 bp Sc-indC-A-Ox-T 
Sc-indC-T-XhoI-HindIII-stop-3   AACTCGAGAAGCTTTCAGCCCCTGCCCTCGGGCTGGAG   
Sc-indC-PacI-NdeI-5 TTAATTAACATATGAGCGTAGAGACCATCCCCTGCT 2370 bp Sc-indC-A-Ox 
Sc-indC-Ox-long-XhoI-stop-3 AACTCGAGTCAGACCAGGCTGATACCGAA   
Sc-indC-TE-NdeI-5 AACATATGGAGGCCACGTCACCCCGGC 1110 bp Sc-indC-TE 
Sc-indC-HindIII-NheI-3 AAGCTTGCTAGCTTTCAGTAGTTGGGCGTCTTGC   
Sc-indC-T-NdeI-5   AACATATGCAGACCACTCAGGAAGCCCAACTGACC 1374 bp Sc-indC-T-TE 
Sc-indC-HindIII-NheI-3 AAGCTTGCTAGCTTTCAGTAGTTGGGCGTCTTGC   
Sc-indC-Ox-NdeI-5 AACATATGCGCGACGAACTCGGTACGAT 435 bp Sc-indC-Ox 
Sc-indC-Ox-XhoI-3 AACTCGAGGAAGCTGCCCAGGTAGTGGT   
Sc-indC-Ox-long-NdeI-5 AACATATGCTGGCCCACCCCGGCTGCC 873 bp Sc-indC-long Ox 
Sc-indC-Ox-long-XhoI-stop-3 AACTCGAGTCAGACCAGGCTGATACCGAA  
Sc-indC-TE-NdeI-5 AACATATGGAGGCCACGTCACCCCGGC 888 bp Sc-indC-TE-2 
Sc-indC-TE-XhoI-stop-3 AACTCGAGTCACACTCCGACCTCCTGGACC  
BpsA-NdeI-5 AACATATGACTCTTCAGGAGACCAGCGTGCTC 3849 bp BpsA 
11924-BpsA-HindIII-3 AAAAGCTTCTCGCCGAGCAGGTAGCGGATGTG  
BpsA-Ox-long-NdeI-5 AACATATGAAGGCGCAGCTGTCCAACCCGG 900 bp BpsA-long Ox 
BpsA-Ox-long-XhoI-stop-3 AACTCGAGTCAGTACTTCAGCCACTCCTCC  
BpsA-Ox-NdeI-5 AACATATGTACTCGCGCAAGGCGGCCGACC 450 bp BpsA-Ox 
BpsA-Ox-XhoI-stop-3 AACTCGAGTCAGTAGTAGTCCTCGTCGGCG  
BpsA-TE-NdeI-5 AACATATGCTGGAGCGCGAGGTCGCCCAG 828 bp BpsA-TE 





BpsA-TE-NcoI-5 AACCATGGTGCTGGAGCGCGAGGTCGCCCAG 828 bp BpsA-TE-2 
11924- BpsA-HindIII-3 AAAAGCTTCTCGCCGAGCAGGTAGCGGATGTG   
BpsA-T-BamHI-NdeI-5 AAGGATTCCATATGGCCGCCTCCGACCAGGTCAAC 327 bp BpsA-T 
BpsA-T-HindIII-EcoRI-3 TTGAATTCAAGCTTAGGCCTTGCCGGTCTCCGCGTGCAG   
BpsA-NdeI-5 AACATATGACTCTTCAGGAGACCAGCGTGCTC 3087 bp BpsA-A-Ox-T 
BpsA-T-HindIII-EcoRI-3 TTGAATTCAAGCTTAGGCCTTGCCGGTCTCCGCGTGCAG  





BpsA-NdeI-5 AACATATGACTCTTCAGGAGACCAGCGTGCTC 2832 bp BpsA-A-Ox 
BpsA-A-Ox-HindIII-3 ATAAGCTTCTCCGTCTCCGTGCGCGGGGCGACGAAG  
Note: the enzyme digestion sites are underlined; “bp” refers to “base pair”.
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Table 3 Plasmids constructed in this study. 
Plasmid Description Ligation sites 
pFC12 Sc-indC in pJET1.2 - 
pFC13 BpsA in pJET1.2 - 
pFC14 BpsA in pET28a NdeI/HindIII 
pFC15 Sc-indC in pET28a NdeI/HindIII 
pFC135 Sc-indC-Ox in pJET1.2 - 
pFC136 Sc-indC-Ox in pET28a NdeI/XhoI 
pFC137 Sc-indC-TE in pJET1.2 - 
pFC138 Sc-indC-long Ox in pJET1.2 - 
pFC139 Sc-indC-TE in pET28a NdeI/XhoI 
pFC140 Sc-indC-long Ox in pET28a NdeI/XhoI 
pFC146 BpsA-TE in pET28a NdeI/XhoI 
pFC147 Sc-indC-A-Ox in pET28a NdeI/XhoI 
pFC148 BpsA-Ox in pET28a NdeI/HindIII 
pYC41 BpsA-A-Ox in pJET1.2 - 
pYC42 BpsA-A-Ox in pET28a NdeI/HindIII 
pYC43 BpsA-A-Ox-T in pJET1.2 - 
pYC44 BpsA-T in pJET1.2 - 
pYC45 BpsA-T-TE in pJET1.2 - 
pYC46 BpsA-T-TE in pCDFDuet-1 NdeI/XhoI 
pYC47 BpsA-TE in pCDFDuet-1 NdeI/XhoI 
pYC48 BpsA-A-Ox-T in pET28a NdeI/HindIII 
pYC49 BpsA-T in pET28a NdeI/HindIII 
pYC50 Sc-indC-A-Ox in pJET1.2 - 
pYC51 Sc-indC-T-TE in pJET1.2 - 
pYC52 Sc-indC-TE in pJET1.2 - 
pYC53 Sc-indC-A-Ox-T in pJET1.2 - 
pYC54 BpsA-TE-2 in pJET1.2 - 
pYC55 Sc-indC-A-Ox in pCDFDuet-1 NdeI/XhoI 
pYC56 Sc-indC-T-TE in pET28a NdeI/HindIII 
pYC57 Sc-indC-TE-2 in pET28a NdeI/HindIII 
pYC58 Sc-indC-A-Ox-T in pCDFDuet-1 NdeI/XhoI 
pYC59 BpsA-TE-2 in pCDFDuet-1 NcoI/HindIII 
 
Table 4 E. coli BAP1 transformants and screening antibiotics. 
Transformants Description Antibiotics Protein/domains 
1 pFC14 K BpsA 
2 pFC15 K Sc-IndC 
3 pFC136 K Sc-IndC-Ox 
4 pFC139 K Sc-IndC-TE 
5 pFC140 K Sc-IndC-long Ox 
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6 pFC146 K BpsA-TE 
7 pFC147 K IndC-A-Ox 
8 pFC148 K BpsA-Ox 
9 pYC42 K BpsA-A-Ox 
10 pYC46 S BpsA-T-TE 
11 pYC42/pYC46 K + S BpsA-A-Ox/BpsA-T-TE 
12 pYC47/pYC48 
 
K + S BpsA-A-Ox-T/BpsA-TE 
13 pYC46/pYC48 
 
K + S BpsA-A-Ox-T/BpsA-T-TE 
14 pYC48 K BpsA-A-Ox-T 
15 pYC49 K BpsA-T 
16 pYC48/pYC59 
 
K + S BpsA-A-Ox/BpsA-T 
17 pYC55/pYC56 
 
K + S Sc-IndC-A-Ox/ Sc-IndC-T-TE 
18 pYC57/pYC58 
 
K + S Sc-IndC-TE/ Sc-IndC-A-Ox-T 
Note: “K” refers to kanamycin, “S” refers to streptomyces. 
2.4 Gene Expression in E. coli BAP1 and Protein Purification 
The pET28a and pCDFDuet-1-derived plasmids were expressed or co-
expressed in E. coli BAP1 (Table 4). Correct transformants 1-18 were selected on 
LB agar supplemented with corresponding antibiotics, and then grown in 50 ml of 
LB broth supplemented with appropriate antibiotics at 37℃ and 250 rpm. When 
the OD600 reached 0.4~0.6, IPTG was added at a final concentration of 200 μM to 
induce the expression at 18℃ or 28℃ for 18-20 hours. 
2.5 SDS-PAGE Analysis of Protein Expression and Purification 
After expression, the cells were collected by centrifugation at 2,100×g for 
10 minutes and resuspended in 5 ml of lysis buffer (20 mM Tris–HCl, 500 mM 
NaCl, pH 7.9). After 5 minutes of ultrasonication (18 W, 45-second interval in 
every 15-second), the resulting lysates were centrifuged at 21,000×g for 30 
minutes. The isoluble proteins were dissolved in 8 M urea. Both soluble and 
insoluble fractions (designated as sample S and sample IS) were analyzed by 10-
12 % SDS-PAGE. 
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The soluble proteins were mixed with 200 μl of HisPur Ni-NTA Resin (Thermo 
Fisher Scientific, Waltham, MA, USA), and incubated at 4℃ for 5 hours, and 
then the mixture was loaded to the gravity-flow column to drain out, which was 
how we got sample F. The packed resin was washed with four resin-bed volumes 
of buffer A (50 mM Tris–HCl, 2 mM EDTA, pH 7.9) (sample A), 25 mM 
imidazole-buffer A (sample 25), and 50 mM imidazole-buffer A (sample 50) in a 
series, and the His-tagged proteins were eluted from the resin with two resin-bed 
volumes of 250 mM imidazole-buffer A (sample 250). Each flow-through was 
collected in a separate tube and subjected to SDS-PAGE to monitor the protein 
elution and purity. The target protein elution was condensed with centrifugal filter 
units (Sigma-Aldrich, St. Louis, MO, USA) at 2,100×g, and stored in the PB 
reaction buffer (50 mM Na2HPO4, 50 mM KH2PO4) with 50% v/v glycerol at -
20℃. 
2.6 Chemical Synthesis of Aminoacyl-N-acetylcysteamine Thioesters: L-
glutamine-SNAC 
We modified a previous method 4 and chemically synthesized L-
glutamine-SNAC (L-Gln-SNAC) (see Figure 5) as a mimicking substrate for in 
vitro enzymatic assays. In step 2, the synthesized aminoacyl-SNAC and Boc-
aminoacyl-SNAC were purified by HPLC with CH3CN/H2O/formic acid 5:95:0.1, 




Figure 5 Protocol for chemical synthesis of L-glutamine-SNAC. 
  
Figure 6 Schematic diagram for chemical synthesis of L-glutamine-SNAC. 
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2.7 Identification of the Substrate and Intermediates 
Characterization of L-Gln: 1H NMR (D2O):  3.77 (1H, dd, J = 4.20, 7.99 
Hz), 2.46 (2H, m), 2.14 (2H, dd, J = 6.98, 13.94 Hz). 
Characterization of L-Gln-SNAC: 1H NMR (D2O):  4.36 (1H, dd, J = 
5.45, 13.44 Hz), 2.87 (2H, m), 2.43 (1H, m), 2.22 (1H, m); ESI-MS: [M+H]+ m/z 
248. 
Characterization of 3-aminopiperidine-2,6-dione (pyro-Gln): 1H NMR 
(D2O):  4.39 (1H, t, J = 6.28 Hz), 3.45 (2H, m), 3.27 (1H, dt, J = 6.35, 13.02 
Hz), 3.16 (1H, m), 2.52 (2H, m), 2.31 (1H, td, J = 7.09, 14.13 Hz), 2.21 (1H, td, J 
= 7.20, 14.70 Hz), 1.98 (3H, s); ESI-MS: [M+H]+ m/z 129. 
2.8 In vitro Enzymatic Reactions  
The in vitro enzymatic reaction system was prepared according to Table 5, 
and reacted at 28℃ for 2 hours. The substrate and intermediates referred to the 
native substrate L-Gln (Sigma-Aldrich, St. Louis, MO, USA), chemically 
synthesized mimicking substrate L-Gln-SNAC, and 3-aminopiperidine-2,6-dione 
(pyro-Gln) (Sigma-Aldrich, St. Louis, MO, USA). 
Table 5 Protocol for in vitro enzyme assay. 
Ingredients Final concentration 
ATP/MgCl2/PB buffer 1 mM/1mM 
Substrate/intermediates 1 mM 
Enzyme 1–10 μΜ 
PB Buffer, pH7.5 50 mM 
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2.9 Analysis of Products 
The in vivo production of indigodine was checked visually or by 
GENESYS 20 ultraviolet spectrophotometer (Thermo Fisher Scientific, Waltham, 
MA, USA).  
The enzymatic reactions were quenched by adding equal volume of 
methanol. The products were centrifuged at 21,000×g for 20 minutes, and the 
supernatants or precipitates (dissolved with DMSO) were injected into the HPLC 
with a gradient mobile phase of CH3CN/H2O (0.1% formic acid) (0:100 – 90:10, 
20 minutes) at 1 ml/minute. 
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CHAPTER III RESULTS 
3.1 PCR for Gene Fragments 
Plasmid pFC14 and pFC15 were used as template for PCR amplification, 
and gene fragments bpsA-A-Ox (2832 bp), bpsA-A-Ox-T (3087 bp), bpsA-T (327 
bp), bpsA-T-TE (1089 bp),  bpsA-TE (828 bp), Sc-indC-A-Ox (2370 bp), Sc-indC-
A-Ox-T (3084 bp), Sc-indC-T-TE (1374 bp), Sc-indC-TE (1110 bp) were obtained 
using corresponding primers listed in Table 2.  
 
Figure 7 PCR result for dissected bpsA gene fragments. 
 
Figure 8 PCR result for dissected Sc-indC gene fragments. 
3.2 Protein Expression and Purification 
Expression plasmids pFC14, 15, 136, 139, 140, 146-148, pYC42, 46-49, 
55-59 (Table 3) were constructed, and were transferred into E. coli BAP1 to get 
transformants 1-18 (Table 4) for protein expression in LB broth. Below are the 
SDS-PAGE analysis for protein expression and purification. 
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Expression of pFC14 (BpsA) (18℃). 
 
Figure 9 SDS-PAGE for the expression of pFC14 (BpsA).  
Note: S-soluble, IS-insoluble, M-protein marker, F-flow through, A-buffer A 
elution, 5-5 mM imidazole/buffer A elution, 10-10 mM imidazole/buffer A 
elution, 250-250 mM imidazole/buffer A elution. 
Expression (18℃) and purification of pYC49 (BpsA-T). 
 
Figure 10 SDS-PAGE for the expression of pYC49 (BpsA-T). 
Expression of pFC136 (Sc-IndC-Ox). 
The plasmid pFC136 was transferred into various E. coli strains including 
E. coli BAP1, E. coli BL21(DE3), E. coli BL21(DE3)-pLysS, E. coli BL21(DE3)-
RIL, and expressed at different temperatures (18 or 28℃). However, all showed 




Figure 11 SDS-PAGE for the expression of pFC136 (Sc-IndC-Ox). 
Expression (28℃) and purification of pFC139 ((Sc-IndC-TE). 
 
Figure 12 SDS-PAGE for the expression of pFC139 ((Sc-IndC-TE). 
Expression (28℃) and purification of pFC146 (BpsA-TE). 
 
Figure 13 SDS-PAGE for the expression of pFC146 (BpsA-TE). 




Figure 14 SDS-PAGE for the expression of pFC147 (Sc-IndC-A-Ox). 
Expression (28℃) and purification of pFC148 (BpsA-Ox). 
 
Figure 15 SDS-PAGE for the expression of pFC148 (BpsA-Ox).  
Table 6 Expression/purification of proteins and dissected domains. 
Plasmid Protein/Domain Expression/Purification 
pFC14 BpsA Purified 
pFC15 Sc-IndC Purified 
pFC136 Sc-IndC-Ox Expressed in insoluble 
pFC139 Sc-IndC-TE Purified 
pFC146 BpsA-TE Purified 
pFC147 Sc-IndC-A-Ox Purified 
pFC148 BpsA-Ox Purified 




3.3 Chemical Synthesis of L-Glutamine-SNAC 
The synthesis of SNAC provided 400 mg N-acetylcysteamine mixture, 
which was confirmed by LC-MS.  
The product mixture of Boc-aminoacyl-SNAC was subjected to LC-MS to 
locate the target compound. 
 
Figure 16 HPLC analysis of the synthesized samples of N-acetylcysteamine and 
Boc-aminoacyl-SNAC. 
 
Figure 17 MS spectra of N-acetylcysteamine and Boc-aminoacyl-SNAC. 
Boc-aminoacyl-SNAC was then purified with HPLC to afford the single 




Figure 18 A typical HPLC trace of Boc-aminoacyl-SNAC purification. 
After deprotection, the mixture was analyzed by LC-MS to locate the 
target compound L-Gln-SNAC, which was finally purified with HPLC to yield 5 
mg of white powder. 
 
Figure 19 LC-MS analysis of aminoacyl-SNAC in the de-protected mixture.  
HPLC trace (top), UV spectrum (bottom left), MS spectrum (bottom right). 
 




Figure 21 Purity check of L-glutamine-SNAC after purification. 
3.4 Characterization of the Substrate and Intermediates 
 
Figure 22 Chemical structures of the substrate and intermediates. 
L-Gln, L-Gln-SNAC, and pyro-Gln were characterized by 1H NMR (D2O). 
Table 7 1H NMR data (500 MHz) for the substrate and intermediates (in D2O). 
Position L-Gln L-Gln-SNAC Pyro-Gln 
2 or 3 3.77 (1H, dd, 8.0, 
4.2) 
4.36 (1H, dd, 
13.4, 5.5) 
4.39 (1H, t, 6.3) 
2 or 3 2.14 (2H, m)  2.43 (1H, m),  
2.22 (1H, m)   
2.52 (2H, m) 
4 2.46 (2H, m) 2.87 (2H, m) 2.31 (1H, td, 14.2, 7.1),  
2.21 (1H, td, 14.2, 7.2) 
1′ or 2′   3.27 (1H, td, 13.0, 6.4),  
3.16 (1H, m) 
1′ or 2′   3.45 (2H, m) 
2′′   1.98 (3H, s) 
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Characterization of L-glutamine. 
 
Figure 23 HPLC analysis of L-glutamine. 
Characterization of L-glutamine-SNAC.  
 
Figure 24 LC-MS analysis of purified L-glutamine-SNAC.  
HPLC trace (top), UV spectrum (bottom left), MS spectrum (bottom right). 




Figure 25 LC-MS analysis of 3-aminopiperidine-2,6-dione hydrochloride.  
HPLC trace (top), UV spectrum (bottom left), MS spectrum (bottom right). 
3.5 In vitro Enzyme Activity and Heterologous Co-expression 
 
Figure 26 Proposed biosynthetic process of indigoidine. 
Enzymatic activity of Sc-IndC and BpsA with L-glutamine, and the effect of 
reaction temperature (18℃ or 28℃).  
It showed that BpsA had higher in vitro activity than Sc-IndC, and the 
effect of the two temperatures on the productivity was not significant (Figure 27). 




Figure 27 Enzymatic activity of Sc-IndC and BpsA with L-glutamine.  
From left to right: Sc-IndC, 18℃; BpsA, 18℃; Sc-IndC, 28℃; BpsA, 28℃. 
Enzymatic activity of BpsA with different amounts of L-glutamine and ATP. 
The substrate L-Gln was tested at 1, 4, and 8 mM. However, no significant 
difference was observed, so 1 mM substrate was applied to the following 
enzymatic reaction system.  
Similarly, ATP was tested in the reactions at 0.5, 1, 2, and 4 mM, 
respectively, and 1 mM ATP worked the best in this system. Higher 
concentrations of ATP might have inhibited the reaction. 
 
Figure 28 Enzymatic activity of BpsA with different amounts of L-glutamine and 
ATP.  
From left to right: 0.5 mM ATP/1 mM L-Gln; 0.5 mM ATP/4 mM L-Gln; 0.5 mM 
ATP/8 mM L-Gln; 1 mM ATP/1 mM L-Gln; 1 mM ATP/4 mM L-Gln; 1 mM 




Figure 29 Enzymatic activity of Sc-IndC and BpsA with different amounts of 
ATP. 
From left to right: BpsA/1 mM ATP; BpsA/2 mM ATP; BpsA/4 mM ATP; Sc-
IndC/1 mM ATP; Sc-IndC/2 mM ATP; Sc-IndC/4 mM ATP. 
Enzymatic activity of BpsA with L-glutamine, 3-aminopiperidine-2,6-dione 
hydrochloride, and L-glutamine-SNAC. 
When BpsA was reacted with L-glutamine, 3-aminopiperidine-2,6-dione 
hydrochloride, and L-glutamine-SNAC, all the reactions turned blue. HPLC and 
UV analysis indicated that indigoidine was synthesized, which was further 
confirmed by MS analysis. These indicated that BpsA not only takes the substrate 
L-Gln, but also converts the intermediate pyro-Gln and the mimicking 
intermediate L-Gln-SNAC to the blue dye.  
Based on the color intensity, we found that the blue color of the L-Gln 
group was deeper than that of pyro-Gln and L-Gln-SNAC. Thus, we supposed that 
though BpsA could convert all these three compounds to indigoidine, it had 




Figure 30 HPLC analysis of the enzymatic reactions of BpsA with L-glutamine, 3-
aminopiperidine-2,6-dione hydrochloride, or L-glutamine-SNAC.  
 
Figure 31 MS spectrum of indigoidine synthesized in the enzymatic reactions. 
Interestingly, in the reaction buffer of BpsA with L-Gln-SNAC, except for 
the production of the blue pigment, the supernatant turned yellowish (as shown in 
Figure 33). LC-MS analysis showed that there was an extra peak of MW 358 
produced (Figure 34 and Figure 35). Further work needs to be done to find the 
structure of this compound. 
Without ATP, neither Sc-IndC nor BpsA can convert these 
substrate/intermediates to indigoidine. 
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Table 8 Enzymatic reaction of BpsA with L-glutamine, 3-aminopiperidine-2,6-
dione hydrochloride, and L-glutamine-SNAC. 
Ingredients Concentration 1 1B 1 2 2B 2 
ATP 1 mM   0 mM   0 mM 
MgCl2 1 mM       




BpsA 15 ul  Inactive   Inactive  
PB, pH7.5 50 mM       
Result  **** / / * / / 
  / / / / / / 
  3 3B 3 4 4B 4 
ATP 1 mM   0 mM   0 mM 
MgCl2 1 mM       












BpsA 15 ul  Inactive   Inactive  
PB, pH7.5 50 mM       
Result  ** / / *** / / 
   / /  / / 
Note:  
“*” Represents there was blue precipitate produced, and the number of “*” indicates 
the color intensity. 
“” Represents the reaction buffer turned yellow, and the number of “” indicates 
the color intensity. 
“1” Indicates there was no ATP added to the reaction buffer. 
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“/” Indicates no apparent color change was observed. 
“Inactive” The BpsA was inactivated by heating at 98℃ for five minutes. 
 
  
Figure 32 In vitro enzymatic reaction of BpsA with L-glutamine, 3-
aminopiperidine-2,6-dione hydrochloride, and L-glutamine-SNAC. 
Top: Picture for all the reaction groups. Bottom left: picture for Group 1-4. 
Bottom right: picture for Group 1-4 after centrifuging at 21,000×g. 
Enzymatic assay of dissected fragments of the indigoidine synthetase.  
With or without ATP or FAD, the TE, Ox, and TE/ Ox domains didn’t work 







Table 9 In vitro enzymatic assay result for the domains′ functional 
characterization. 
Enzyme assay Enzymes Color change LC-MS 
pFC139, L-Gln Sc-indC-TE / / 
pFC139, L-Gln-SNAC Sc-indC-TE / / 
pFC139, pyro-Gln Sc-indC-TE / / 
pFC140, L-Gln Sc-IndC-LOx / / 
pFC140, pyro-Gln Sc-IndC-LOx / / 
pFC146, L-Gln BpsA-TE / / 
pFC146, L-Gln-SNAC BpsA-TE / / 
pFC146, pyro-Gln BpsA-TE / / 
pFC146/pFC147, L-Gln BpsA-TE, Sc-IndC-A-Ox / / 
pFC146/pFC147, pyro-Gln BpsA-TE, Sc-IndC-A-Ox / / 
pFC147, L-Gln Sc-IndC-A-Ox / / 
pFC147, pyro-Gln Sc-IndC-A-Ox / / 
pFC148, L-Gln BpsA-Ox / / 
pFC148, L-Gln-SNAC BpsA-Ox / / 
pFC148, pyro-Gln BpsA-Ox / / 




Figure 33 In vitro reactions of BpsA or dissected fragments of BpsA/Sc-IndC 
with L-glutamine-SNAC.  
From left to right: BpsA/L-Gln; BpsA/L-Gln-SNAC; BpsA-TE/L-Gln-SNAC; Sc-
IndC-A-Ox/L-Gln-SNAC, blank control (without any enzyme). 
 
Figure 34 LC-MS analysis of the reaction products in the supernatant.  
Possible molecule weights of the peaks were labeled based on the MS analysis. 




Figure 35 UV and MS spectra for the enzymatic reaction product of molecular 
weight 358. 
 
Figure 36 Time course analysis of the in vitro reaction of BpsA with L-glutamine. 
The time course analysis of the in vitro reaction of BpsA with L-Gln showed 
that the indigoidine production increased with the reaction time.  
LC-MS analysis (not shown in this paper) for the supernatant taken at t = 
15 minute, 30 minute, 1 hour, and 2 hours showed similar HPLC traces, and no MS 
















and indigoidine (248) were tracked, likely due to the extremely low amounts. 
Signals of ATP and its derivatives were found (ATP, ADP, and AMP). 
Heterologous co-expression.  
Heterologous co-expression of transformants 11-13, 16-18 (Table 4) in LB 
at 18℃ or 28℃ didn’t get the blue dye, while the positive control E. coli 
BAP1/pFC15 turned deep blue. HPLC analysis of these co-expression experiments 




CHAPTER IX DISCUSSION AND CONCLUSIONS 
We live in a world full of pigments. Chemical synthesis has been a 
predominant source of pigments in industry, which not only brings serious 
environmental pollution, but also raises health concerns, especially from the 
applications in food, medical, and cosmetic industries. An alternative to 
traditional chemical method is biosynthesis, which is environmentally 
advantageous with regard to sustainability and less chemical hazards. 
Biosynthetic natural products have better safety profiles than those chemically 
synthesized for food and pharmaceutical applications. Hence natural colorants and 
dyes have been of great interest with the increasing attention to environment 
protection and human health. 
Indigoidine is a bacteria-derived natural blue dye. It has the advantages of 
antioxidant and anti-microbial activities. Technically, the responsible biosynthetic 
genes are more compatible to be recombinated in engineering host models for 
large-scale production. Previously, we expressed Sc-indC in E. coli BAP1 and 
reached a production of ~20 g/L using L-glutamine in a batch fermentation. In 
another case, an engineered yeast with bpsA produced indigoidine reaching titers 
of ~86 g/L using glucose in a fed-batch fermentation. These indicate that 
indigoidine has great potential to be produced in mass production by biosynthetic 
approach. To further improve the production, this study dedicated to reveal the 




In this study, both BpsA and Sc-IndC were functionally expressed in E. 
coli BAP1, which confirmed that their catalytic activity can reconstituted in vitro. 
This provided a great platform for the following study on the catalytic domains in 
these modular NRPSs.  
By dissecting the indigoidine synthetic genes Sc-indC and bpsA, we 
established a library of biosynthetic bricks with four biosynthetic domains, 
including A, Ox, T, and TE domain. The dissected domains were co-expressed in 
E. coli BAP1 in different combinations, or expressed individually and purified for 
in vitro enzymatic assay to test their function in the biosynthesis of indigoidine. 
The intermediate L-Gln-SNAC, an aminoacyl-N-acetylcysteamine 
thioester (aminoacyl-SNAC) was chemically synthesized and characterized. In 
vitro enzymatic assay showed that the intact BpsA enzyme could take it as a 
precursor to synthesize indigoidine. 
BpsA, as an intact enzyme, with the presence of ATP, worked on the 
native substrate, L-Gln, the intermediate, pyro-Gln, and the mimicking 
intermediate, L-Gln-SNAC, to produce indigoidine. However, no predicted 
intermediates, according to the proposed biosynthetic pathway from the literature, 
were detected by LC-MS during the reaction process. Furthermore, in the reaction 
of BpsA with L-Gln-SNAC, there was a molecule of MW 358 produced, which 
might contribute to the emerged yellow color in the reaction buffer and might be a 
possible intermediate produced in the biosynthetic process of indigoidine. 
When the indigoidine synthetases were split into domains and worked 
individually on the native substrate L-Gln or the intermediates, neither putative 
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intermediates nor the final product indigoidine was detected. Even when various 
domains were co-existed in vitro, no apparent activity was observed. For the co-
expression of the combinations of dissected domains A-Ox/T-TE, A-Ox-T/TE, no 
blue dye was produced, which indicates no apparent activity of the dissected 
domains neither. It is possible that the in vitro reaction system or fermentation 
condition not benefit the enzymatic activities of the dissected domains. But we 
cannot exclude the possibility that the truncated and dissected enzymes might 
have less activity or maybe even inactive. In this case, the reaction methods need 
to be further optimized. Alternatively, gene deficit or site-directed mutagenesis, 
rather than dissection and co-expression methods, might be applied to study the 
biosynthetic mechanism of the indigoidine biosynthetic process. 
This study provided important platforms and technical basis for further 
study on the biosynthetic mechanism of indigoidine. Further work needs to be 





Figure 37 1H NMR spectrum of L-glutamine (in D2O). 
 




Figure 39  1H NMR spectrum of 3-aminopiperidine-2,6-dione (in D2O). 
 
Figure 40 HPLC trace and UV spectrum of indigoidine. 
 
